Skip to main content

Table 4 Validation of predictive factors for TIA (n = 377; number of events = 92)

From: Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction

  

Agec

HT

DM

Age + HT

Age + DM

HT + DM

Age + HT + DM

Single risk

TIA ( +)

73

60

27

53

25

21

21

TIA (-)

79

57

11

28

5

5

2

PPVd

48.0%

51.3%

71.1%

65.4%

83.3%

80.8%

91.3%

Single risk + ALDOA-Aba

TIA ( +)

53

47

21

41

20

17

17

TIA (-)

31

27

2

12

1

0

0

PPV

63.1%

63.5%

91.3%

77.4%

95.2%

100.0%

100.0%

Single risk + FH-Abb

TIA ( +)

39

33

16

29

14

14

13

TIA (-)

24

25

1

12

0

1

0

PPV

61.9%

56.9%

94.1%

70.7%

100.0%

93.3%

100.0%

Single risk + ALDOA-Ab + FH-Ab

TIA ( +)

32

29

15

25

14

13

13

TIA (-)

11

14

0

7

0

0

0

PPV

74.4%

67.4%

100.0%

78.1%

100.0%

100.0%

100.0%

  1. aADOLA-Ab, elevated ADOLA-Ab levels, > 14,869
  2. bFH-Ab, elevated FH-Ab levels, > 2,849
  3. cAge, ≥ 60
  4. dPPV, positive predictive value